Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

What have we learned from the time trend of mass shootings in the U.S.?

Lin PI, Fei L, Barzman D, Hossain M.

PLoS One. 2018 Oct 18;13(10):e0204722. doi: 10.1371/journal.pone.0204722. eCollection 2018.

2.

An Atypical Presentation of Pediatric Acute Neuropsychiatric Syndrome Responding to Plasmapheresis Treatment.

Barzman DH, Jackson H, Singh U, Griffey M, Sorter M, Bernstein JA.

Case Rep Psychiatry. 2018 Jun 28;2018:8189067. doi: 10.1155/2018/8189067. eCollection 2018.

3.

Automated Risk Assessment for School Violence: a Pilot Study.

Barzman D, Ni Y, Griffey M, Bachtel A, Lin K, Jackson H, Sorter M, DelBello M.

Psychiatr Q. 2018 Dec;89(4):817-828. doi: 10.1007/s11126-018-9581-8.

PMID:
29713946
4.

Eye Gaze Patterns Associated with Aggressive Tendencies in Adolescence.

Laue C, Griffey M, Lin PI, Wallace K, van der Schoot M, Horn P, Pedapati E, Barzman D.

Psychiatr Q. 2018 Sep;89(3):747-756. doi: 10.1007/s11126-018-9573-8.

PMID:
29552711
5.

The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.

Mossman SA, Luft MJ, Schroeder HK, Varney ST, Fleck DE, Barzman DH, Gilman R, DelBello MP, Strawn JR.

Ann Clin Psychiatry. 2017 Nov;29(4):227-234A.

6.

White matter volumes in youth offspring of bipolar parents.

Nery FG, Norris M, Eliassen JC, Weber WA, Blom TJ, Welge JA, Barzman DA, Strawn JR, Adler CM, Strakowski SM, DelBello MP.

J Affect Disord. 2017 Feb;209:246-253. doi: 10.1016/j.jad.2016.11.023. Epub 2016 Nov 25.

PMID:
27936454
7.

Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania.

Welge JA, Saliba LJ, Strawn JR, Eliassen JC, Patino LR, Adler CM, Weber W, Schneider MR, Barzman DH, Strakowski SM, DelBello MP, McNamara RK.

J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):980-989. doi: 10.1016/j.jaac.2016.08.006. Epub 2016 Sep 13.

PMID:
27806866
8.

A Pilot Study on Developing a Standardized and Sensitive School Violence Risk Assessment with Manual Annotation.

Barzman DH, Ni Y, Griffey M, Patel B, Warren A, Latessa E, Sorter M.

Psychiatr Q. 2017 Sep;88(3):447-457. doi: 10.1007/s11126-016-9458-7.

PMID:
27528455
9.

Beyond DSM-5 and IQ Scores: Integrating the Four Pillars to Forensic Evaluations.

Delgado SV, Barzman DH.

Psychiatr Q. 2017 Mar;88(1):199-211. doi: 10.1007/s11126-016-9443-1.

PMID:
27289591
10.

Pediatric asthma and autism-genomic perspectives.

Oh S, Ji H, Barzman D, Lin PI, Hutton J.

Clin Transl Med. 2015 Dec;4(1):37. doi: 10.1186/s40169-015-0078-x. Epub 2015 Dec 14.

11.

Review of the genetic basis of emotion dysregulation in children and adolescents.

Barzman D, Geise C, Lin PI.

World J Psychiatry. 2015 Mar 22;5(1):112-7. doi: 10.5498/wjp.v5.i1.112. Review.

12.

Correlations of inflammatory gene pathways, corticolimbic functional activities, and aggression in pediatric bipolar disorder: a preliminary study.

Barzman D, Eliassen J, McNamara R, Abonia P, Mossman D, Durling M, Adler C, DelBello M, Lin PI.

Psychiatry Res. 2014 Nov 30;224(2):107-11. doi: 10.1016/j.pscychresns.2014.07.009. Epub 2014 Aug 15.

13.

Pediatric emotion dysregulation: biological and developmental evidence for a dimensional approach.

Geise C, Barzman D, Strakowski S.

Psychiatr Q. 2014 Sep;85(3):383-9. doi: 10.1007/s11126-014-9300-z. Review.

PMID:
24907104
14.

The impact of ADHD on morality development.

Groman CM, Barzman DH.

Atten Defic Hyperact Disord. 2014 Jun;6(2):67-71. doi: 10.1007/s12402-014-0131-4. Epub 2014 Mar 16.

PMID:
24633571
15.

Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study.

Strawn JR, Adler CM, McNamara RK, Welge JA, Bitter SM, Mills NP, Barzman DH, Cerullo MA, Chang KD, Strakowski SM, DelBello MP.

Bipolar Disord. 2014 Aug;16(5):523-30. doi: 10.1111/bdi.12113. Epub 2013 Aug 13.

PMID:
23937313
16.

The association between salivary hormone levels and children's inpatient aggression: a pilot study.

Barzman DH, Mossman D, Appel K, Blom TJ, Strawn JR, Ekhator NN, Patel B, DelBello MP, Sorter M, Klein D, Geracioti TD Jr.

Psychiatr Q. 2013 Dec;84(4):475-84. doi: 10.1007/s11126-013-9260-8.

PMID:
23508357
17.

Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.

Patel BD, Barzman DH.

Psychiatr Q. 2013 Dec;84(4):407-15. doi: 10.1007/s11126-013-9253-7. Review.

PMID:
23443759
18.

Brief Rating of Aggression by Children and Adolescents (BRACHA): a reliability study.

Barzman D, Mossman D, Sonnier L, Sorter M.

J Am Acad Psychiatry Law. 2012;40(3):374-82.

PMID:
22960920
19.

The Missing Link between Juvenile Delinquency and Pediatric Posttraumatic Stress Disorder: An Attachment Theory Lens.

Amatya PL, Barzman DH.

ISRN Pediatr. 2012;2012:134541. doi: 10.5402/2012/134541. Epub 2012 Jun 14.

20.

Brief Rating of Aggression by Children and Adolescents (BRACHA): development of a tool for assessing risk of inpatients' aggressive behavior.

Barzman DH, Brackenbury L, Sonnier L, Schnell B, Cassedy A, Salisbury S, Sorter M, Mossman D.

J Am Acad Psychiatry Law. 2011;39(2):170-9.

PMID:
21653259
21.

Pharmacologic management of acutely agitated pediatric patients.

Sonnier L, Barzman D.

Paediatr Drugs. 2011 Feb 1;13(1):1-10. doi: 10.2165/11538550-000000000-00000. Review.

PMID:
21162596
22.

Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?

Barzman DH, Patel A, Sonnier L, Strawn JR.

Neuropsychiatr Dis Treat. 2010 Oct 11;6:691-7. doi: 10.2147/NDT.S5832.

23.

Evidence-based recommendations for the treatment of aggression in pediatric patients with attention deficit hyperactivity disorder.

List BA, Barzman DH.

Psychiatr Q. 2011 Mar;82(1):33-42. doi: 10.1007/s11126-010-9145-z. Review.

PMID:
20652408
24.

Recommendations for pharmacological management of inpatient aggression in children and adolescents.

Deshmukh P, Kulkarni G, Barzman D.

Psychiatry (Edgmont). 2010 Feb;7(2):32-40.

25.

Collaborative problem solving (CPS) as a primary method of addressing acute pediatric pathological aggression along with other modalities.

Kulkarni G, Deshmukh P, Barzman D.

Psychiatr Q. 2010 Jun;81(2):167-75. doi: 10.1007/s11126-010-9126-2. Review.

PMID:
20165915
26.

Pharmacological treatment of pathologic aggression in children.

Barzman DH, Findling RL.

Int Rev Psychiatry. 2008 Apr;20(2):151-7. doi: 10.1080/09540260801887819. Review.

PMID:
18386205
27.

Response to duloxetine in a depressed, treatment-resistant adolescent female.

Delgado SV, SaldaƱa SN, Barzman DH, Coffey B.

J Child Adolesc Psychopharmacol. 2007 Dec;17(6):889-94. doi: 10.1089/cap.2007.1764. No abstract available.

PMID:
18315460
28.

Medical management of pediatric mood disorders.

Singh MK, Pfeifer JC, Barzman DH, Kowatch RA, DelBello MP.

Pediatr Ann. 2007 Sep;36(9):552-63. No abstract available.

PMID:
17910203
29.

A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.

Barzman DH, DelBello MP, Forrester JJ, Keck PE Jr, Strakowski SM.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):503-9.

PMID:
17822344
30.

Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics.

Patel NC, Hariparsad M, Matias-Akthar M, Sorter MT, Barzman DH, Morrison JA, Stanford KE, Strakowski SM, DelBello MP.

J Child Adolesc Psychopharmacol. 2007 Jun;17(3):303-11.

PMID:
17630864
31.

Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder.

Barzman DH, DelBello MP, Fleck DE, Lehmkuhl H, Strakowski SM.

Bipolar Disord. 2007 Jun;9(4):339-44.

PMID:
17547580
32.
33.

Topiramate for co-occurring bipolar disorder and disruptive behavior disorders.

Barzman DH, Delbello MP.

Am J Psychiatry. 2006 Aug;163(8):1451-2. No abstract available.

PMID:
16877668
34.

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.

Delbello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM.

J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):305-313. doi: 10.1097/01.chi.0000194567.63289.97.

PMID:
16540815
35.

Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders.

Barzman DH, DelBello MP, Kowatch RA, Warner J, Rofey D, Stanford K, Rappaport K, Daniels JP, Strakowski SM.

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):931-7.

PMID:
16379513
36.

Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?

Barzman DH, McConville BJ, Masterson B, McElroy S, Sethuraman G, Moore K, Kahwaty AM, Nelson D.

J Affect Disord. 2005 Nov;88(3):279-85. Epub 2005 Sep 16.

PMID:
16169087
37.

The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.

Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM.

J Child Adolesc Psychopharmacol. 2004 Winter;14(4):593-600.

PMID:
15662152
38.

Quetiapine for chronic motor tic disorder.

Barzman D, Gernert B, Delbello M.

Am J Psychiatry. 2004 Jul;161(7):1307. No abstract available.

PMID:
15229071
39.

Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.

Barzman DH, Fieler L, Sallee FR.

J Leg Med. 2004 Mar;25(1):23-38. Review. No abstract available.

PMID:
15208788
40.

Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment.

Barzman DH, Fieler L, Sallee FR.

J Leg Med. 2004;25(1):23-38. No abstract available.

PMID:
15204912
41.

Effect of patient and family insight on compliance of schizophrenic patients.

Smith CM, Barzman D, Pristach CA.

J Clin Pharmacol. 1997 Feb;37(2):147-54.

PMID:
9055141

Supplemental Content

Loading ...
Support Center